Search for the latest oncology news by tumour type
Common asbestos lung disease does not increase risk of lung cancer
People who are diagnosed with the most common form of asbestos-related lung disease are not…
Browsing: Tumour Stream
Lymphoma patients may have new path to remission, even when CAR T therapy fails
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant…
ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma
Adding daratumumab to carfilzomib and dexamethasone to treat patients with relapsed or refractory multiple myeloma…
ASH 2019: Immunotherapy superior to chemotherapy for children with relapsed B-ALL
The immunotherapy drug blinatumomab significantly improved survival in children with relapsed B-acute lymphoblastic leukaemia (B-ALL)…
ASH 2019: Daratumumab shows overall survival benefit and continued improvement in progression-free survival in patients with newly diagnosed multiple myeloma who are ineligible for transplant
The phase 3 ALCYONE study showed the addition of daratumumab to bortezomib, melphalan and prednisone (D-VMP) improved…
Anti-CTLA-4 antibody tremelimumab shows efficacy in patients with metastatic bladder cancer
Treatment with the investigational anti-CTLA-4 agent tremelimumab showed clinical responses in patients with pretreated metastatic…
ASH 2019: Combination therapy aimed at slowing the progression of a precursor myeloma condition
Investigators presented results of a phase II trial of a combination of three oral drugs…
ASH 2019: Novel immunotherapy agent for multiple myeloma shows promising pre-clinical results
Promising pre-clinical results using a bispecific T-cell engager (BiTE), an experimental immunotherapy agent to attack…
ASH 2019: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma
A new analysis shows that a donor stem cell transplant following treatment with an immune…
New test predicts chance of living more than a year on targeted breast cancer treatment
A new test could pick out women with advanced breast cancer who are likely to benefit from…